Cargando…
Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years
We report three cases of nonmetastatic prostate cancer treated effectively with long‐term primary intermittent androgen deprivation (IAD). IAD is not a standard therapy for patients with nonmetastatic prostate cancer. However, based on our experience, we suggest that IAD is one of useful therapeutic...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378862/ https://www.ncbi.nlm.nih.gov/pubmed/28396761 http://dx.doi.org/10.1002/ccr3.854 |
_version_ | 1782519495226556416 |
---|---|
author | Shida, Yohei Hakariya, Tomoaki Miyata, Yasuyoshi Sakai, Hideki |
author_facet | Shida, Yohei Hakariya, Tomoaki Miyata, Yasuyoshi Sakai, Hideki |
author_sort | Shida, Yohei |
collection | PubMed |
description | We report three cases of nonmetastatic prostate cancer treated effectively with long‐term primary intermittent androgen deprivation (IAD). IAD is not a standard therapy for patients with nonmetastatic prostate cancer. However, based on our experience, we suggest that IAD is one of useful therapeutic tools under certain patients’ condition. |
format | Online Article Text |
id | pubmed-5378862 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-53788622017-04-10 Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years Shida, Yohei Hakariya, Tomoaki Miyata, Yasuyoshi Sakai, Hideki Clin Case Rep Case Reports We report three cases of nonmetastatic prostate cancer treated effectively with long‐term primary intermittent androgen deprivation (IAD). IAD is not a standard therapy for patients with nonmetastatic prostate cancer. However, based on our experience, we suggest that IAD is one of useful therapeutic tools under certain patients’ condition. John Wiley and Sons Inc. 2017-02-23 /pmc/articles/PMC5378862/ /pubmed/28396761 http://dx.doi.org/10.1002/ccr3.854 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Shida, Yohei Hakariya, Tomoaki Miyata, Yasuyoshi Sakai, Hideki Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years |
title | Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years |
title_full | Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years |
title_fullStr | Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years |
title_full_unstemmed | Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years |
title_short | Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years |
title_sort | three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378862/ https://www.ncbi.nlm.nih.gov/pubmed/28396761 http://dx.doi.org/10.1002/ccr3.854 |
work_keys_str_mv | AT shidayohei threecasesofnonmetastaticprostatecancertreatedsuccessfullywithprimaryintermittentandrogendeprivationtherapyover10years AT hakariyatomoaki threecasesofnonmetastaticprostatecancertreatedsuccessfullywithprimaryintermittentandrogendeprivationtherapyover10years AT miyatayasuyoshi threecasesofnonmetastaticprostatecancertreatedsuccessfullywithprimaryintermittentandrogendeprivationtherapyover10years AT sakaihideki threecasesofnonmetastaticprostatecancertreatedsuccessfullywithprimaryintermittentandrogendeprivationtherapyover10years |